Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bristol-Myers Squibb Announces Dividend.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- The Board of Directors of Bristol-Myers Squibb Company (NYSE NYSE

See: New York Stock Exchange
: BMY BMY Bristol Myers Squibb ) declared a quarterly dividend of thirty-one cents ($0.31) per share on the $.10 par value Common Stock of the corporation. The quarterly dividend will be payable on November 2, 2009 to stockholders of record at the close of business on October 2, 2009.

The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock Convertible Preferred Stock

Preferred stock that includes an option for the holder to convert the preferred shares into a fixed number of common shares, usually anytime after a predetermined date. Also known as "convertible preferred shares".
 of the corporation, payable December 1, 2009 to stockholders of record at the close of business on November 6, 2009.

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life. For more information, visit: www.bms.com.
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 9, 2009
Words:120
Previous Article:Discover Financial Services Announces Third Quarter 2009 Earnings Release and Conference Call.
Next Article:Orthofix International to Participate in Morgan Stanley Global Healthcare Unplugged Conference.
Topics:



Related Articles
CB Richard Ellis Group, Inc.
Bristol-Myers spins off device unit for $4.1 billion.
Bristol-Myers Squibb, Biocon's Syngene open new R and D facility at Biocon Park.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles